Nalmefene in alcohol misuse: junk evaluation by the European Medicines AgencyBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g2017 (Published 10 March 2014) Cite this as: BMJ 2014;348:g2017
- Alain Braillon, public health doctor1
- 1Northern Hospital, 80000 Amiens, France
“If you torture the data long enough, it will confess.” Ronald Coase.
Spence claims that nalmefene in alcohol misuse is bad medicine.1 In my opinion it is junk evaluation by the European Medicines Agency.
Firstly, the authorisation was granted on subgroup analysis of two randomised controlled studies of six months’ duration.2 This subgroup comprised only a quarter …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial